The Wegovy pill is still dominating the GLP-1 pill market
It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.
Search fresh public links, source activity, and ready-to-use post angles for Wegovy.
Fresh curated links around Wegovy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.
Thousands of people begin receiving their first deliveries of once-a-day medication made by Novo NordiskBusiness live – latest updatesA once-a-day Wegovy weight-loss pill has gone...
The daily tablet, called the Wegovy Pill, is expected to get the greenlight from health officials, according to sources close to the drug's developer, the Danish firm Novo Nordisk.
The once-a-day pill, from the makers of the Wegovy weight-loss jab, can now be bought privately in UK pharmacies.
Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
The UK's first Wegovy weight loss pill is now available. Here's how much it costs, how it compares with injections and what pharmacists say patients should know.
The drug works as an appetite suppressant by mimicking a hormone that makes people feel fuller, which can help them lose weight.
It has been hailed as a game‑changing moment for slimmers. Earlier this month, a new pill form of Wegovy - the blockbuster weight‑loss jab - was approved for use in the UK.
Plans to file with the Indian regulator too, seeking approvals for the higher dose
The drugmaker aims for berobenatide to be the first monthly GLP-1 weight-loss injection, distinguishing it from blockbuster drugs like Wegovy and Eli Lilly’s Zepbound
The drug is given on prescription and will be available within weeks
Eli Lilly announced clinical trial results for retatrutide, its next gen obesity drug. The drug helped study participants lose 70 lbs over 80 weeks, making it more powerful than Ze...
Experts say the future of obesity treatment will extend far beyond GLP-1 drugs by combining medications with personalized therapies and advanced procedures. The arrival of GLP-1 me...
Regulator approval means patients who meet criteria will be able to purchase tablets with private prescription Patients in the UK will soon be able to buy the Wegovy weight-loss pi...
Metabolic (formerly GluCare.Health), the UAE’s leading tech-enabled metabolic health platform, today announced it will offer early access to Wegovy pill (oral semaglutide), Novo No...
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements for people with type 2 diabetes than the leading oral semaglutide in...
A Medicare pilot program could expand access to GLP-1 weight-loss drugs for millions of seniors while lowering monthly costs to about $50.
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
Doctors say a pill version of the weightloss injectable Wegovy will make treatment more accessible for Australians.
A new analysis is raising concerns about Wegovy, the blockbuster weight-loss drug, after researchers found it may carry the highest risk of a rare “eye stroke” that can cause sudde...
Turning to medications to help you reach your weight loss goals was once taboo, but with new advancements and telehealth platforms offering options such as Wegovy, Ozempic, and oth...
OTTAWA — Health Canada has approved the first generic semaglutide injection for weight loss. The product from the Canadian company Apotex is known as Svemia and is a generic versio...
Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.